Purinergic Signaling as a Longevity Target: Therapeutic Frontiers and Systems-Level Mechanisms
Explore the advanced molecular architecture of purinergic stress signaling — from transcriptional reprogramming and metabolic crosstalk to emerging therapeutic strategies targeting CD38, P2X7, and the ectonucleotidase axis in aging.
